-
Supreme Court to Hear Asbestos Exposure Case That Will Impact Mesothelioma Victims
There have been countless mesothelioma victims whose lawsuits against the companies they blame for their illness have run up against the “bare metal defense” – where a manufacturer whose equipment uses an asbestos-containing component denies responsibility because that component was provided by a third party supplier. Those cases have been emotional roller coasters, as some
-
Family Prevails in Mesothelioma Wrongful Death Lawsuit
The Court of Appeals of California recently resolved a contentious mesothelioma lawsuit in which an asbestos company attempted to deny the children of a deceased man the right to pursue wrongful death claims. The case pitted Elementis Chemicals, Inc. against the adult children of Marty Marteney, who died of mesothelioma in January of 2015.
-
UK Mesothelioma Nurse Receives $10,500 Quality of Life Grant
Mesothelioma research tends to focus in on the hard science of the disease: biomarkers, cells, the impact of specific medications or doses of radiation. By contrast, far fewer studies are done on the real-life impact that the disease has on the lives of its victims – how facing a rare and fatal form of cancer
-
Compound in Cow’s Milk May Help Kill Malignant Mesothelioma Cells
When you were a kid and your mother told you to drink your milk, you probably never dreamed that the white stuff you poured over your cereal might hold the key to curing malignant mesothelioma. Though it would definitely be a stretch to think that drinking more cow’s milk could eradicate the asbestos-related disease, as
-
Penn Study Ties Improved Radiotherapy Technology to Better Mesothelioma Outcomes
Though most patients diagnosed with malignant mesothelioma are treated using a multimodality treatment combining surgery, chemotherapy, and radiation therapy, it has long been accepted that radiation therapy provides the least benefit of the three. Though the tool can effectively kill cells, its lack of precision has made it unwieldy when treating the challenging landscape of
-
New Jersey Jury to Hear Second Baby Powder Mesothelioma Case
In the next several months, juries all over the United States will be hearing testimony about asbestos in Johnson & Johnson’s Baby Powder causing mesothelioma and other forms of cancer. In New Jersey, one such trial resulted in a verdict of $117 million for a mesothelioma victim, and now a new jury has been seated
-
Identification of Mesothelioma “Fingerprint” Opens Many New Doors
Mesothelioma researchers have long hoped to find a conclusive way of identifying whether a patient’s cancer was caused by exposure to asbestos, and now a group of Italian scientists say that they have accomplished that goal. Researchers from the Marche Polytechnic University in Ancona, Italy recently identified a microRNA “signature” that is consistently found in
-
Young Woman’s Mesothelioma Attributed to Charity Work Done As A Teen
When we hear about a death from malignant mesothelioma, we tend to immediately picture an elderly man – perhaps a laborer or veteran of the U.S. Navy. But mesothelioma recently claimed the life of a 33-year-old woman in the United Kingdom who was exposed to asbestos as a teenager. Rose Wharton was a medical researcher
-
New York Appeals Court Rules In Favor of Mesothelioma Clients, Against Asbestos Companies,
When people are diagnosed with malignant mesothelioma, they have several decisions that they need to make, including what type of treatment protocol they want to pursue, how to handle their family affairs, and whether to pursue legal action against those who are responsible. In many cases, the responsible parties are companies whose products were contaminated
-
UK Mesothelioma Research Director Discusses Their Latest Work
The Director of the Imperial College London’s National Center for Mesothelioma Research has high hopes for a future cure for the rare and fatal form of cancer. Sitting down for an interview with reporters from the college for a comprehensive interview, Dr. Maija Maskunitty spoke extensively about the research that the center has been conducting,
-
Celebrating Mesothelioma Awareness Day 2018
This year as every year since 2004, September 26th is being celebrated as Mesothelioma Awareness Day. The purpose of the day is to call attention to the plight suffered by those who have been diagnosed with this rare and fatal form of cancer, as well as to all victims of asbestos exposure. For 2018, the
-
United Kingdom Coroner Urging Mesothelioma Screening Following Fatal Apartment Fire
In the aftermath of one of the deadliest fires in United Kingdom history, that country’s coroner is urging that both residents and first responders who were exposed to the conflagration need to be screened for mesothelioma and other asbestos-related illnesses as a result of asbestos exposure from the structure. Dr. Fiona Wilcox voiced her concerns
-
Study Shows that Women With Mesothelioma Fare Better Than Men
Though malignant mesothelioma is more commonly diagnosed in men, women who have been exposed to asbestos are also at risk for the disease, and are frequently diagnosed and treated for the condition. Now a study conducted by Australian researchers has looked at both the disparity in rate of diagnosis and the difference in survival among
-
Georgia Police Officer Awarded $7 Million in New York Mesothelioma Lawsuit
James Stock, Jr.’s career as a police officer puts him in the line of danger every day, but it was his years before he entered law enforcement that are responsible for the mesothelioma that will eventually claim his life. Stock, who lives in Atlanta, Georgia, joined the police force as a career, after years of
-
Japanese Researchers Find Success With Radiofrequency Ablation, A New Mesothelioma Treatment
In the course of their disease, mesothelioma patients often experience debilitating pain caused by their growing tumors. Radiofrequency ablation, a protocol that uses electrical energy to kill cancer cells by heating them up, has proven to be one of the most effective treatments available. Now a group of Japanese researchers from the Hyogo College of
-
Co-Defendant in Baby Powder Mesothelioma Case Agrees to Settle
Following a series of guilty verdicts and hefty damages owed, the company that supplies talc to Johnson & Johnson for their baby powder has agreed to settle with the California woman blaming the two companies for her mesothelioma diagnosis. Carolyn Weirick’s lawsuit against Imerys and Johnson & Johnson asserts that the iconic consumer product’s talc
-
Mesothelioma Specialists in the United Kingdom to Stop Recommending Surgery
In a dramatic departure from mesothelioma treatment in the United States, specialists in the United Kingdom have decided they will no longer recommend aggressive surgery as part of patient care unless the procedures are being studied as part of a specific study. This decision, which is outlined in the Mesothelioma Management Guidelines for 2018 just
-
Virus Therapy May Provide New Path for Mesothelioma Treatment
In the face of disappointing results from traditional cancer treatments like chemotherapy and radiation therapy, mesothelioma researchers are increasingly turning to novel approaches. A recent report from the University of Leeds in England and the Institute of Cancer Research in London may have opened a new line of inquiry for those specializing in treating the
-
Latest Johnson & Johnson Baby Powder Mesothelioma Case Goes to Jury
After hearing four weeks worth of evidence in a California woman’s lawsuit against pharmaceutical giant Johnson & Johnson, a jury will be deciding whether asbestos in the company’s baby powder product caused her malignant mesothelioma. During closing arguments on Thursday, Carolyn Weirick’s attorney argued that the company owed her $29 million in compensation plus additional
-
Baylor Announces Arrival of Dr. Taylor Ripley
In the wake of the death of Dr. David Sugarbaker, Baylor College of Medicine has announced that mesothelioma specialist Dr. Taylor Ripley will be joining the Michael E. DeBakey Department of Surgery in their Division of General Thoracic Surgery as an associate professor of surgery. Dr. Ripley has extensive expertise in thoracic surgical oncology and
